Your shopping cart is currently empty

VU6000918 is a positive allosteric modulator that targets the muscarinic acetylcholine receptor subtype M4. It exhibits a half maximal effective concentration (EC50) of 19 nM for the human M4 receptor.


| Description | VU6000918 is a positive allosteric modulator that targets the muscarinic acetylcholine receptor subtype M4. It exhibits a half maximal effective concentration (EC50) of 19 nM for the human M4 receptor. |
| Targets&IC50 | M4 (human):19 nM (EC50) |
| In vitro | VU6000918 significantly reverses AHL by 18% at a minimal oral dosage of 0.03 mg/kg and achieves peak reversal of 74% with a 3 mg/kg dosage, yielding an in vivo plasma EC50 of 74 nM (0.66 nM unbound) according to terminal concentrations observed in study animals 1.5 hours after administering compound 17j[1]. |
| Molecular Weight | 389.42 |
| Formula | C18H17F2N5OS |
| Cas No. | 2101737-32-8 |
| Smiles | Cc1nnc2sc(C(=O)NC3CN(C3)c3cccc(F)c3F)c(N)c2c1C |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.